Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Pharmacol Ther. 2016 Dec 1;170:212–225. doi: 10.1016/j.pharmthera.2016.11.011

Figure 2. Pharmacological and immunological agents with the potential to target mesenchymalization in solid tumors.

Figure 2

Selected agents used for signaling pathway inhibition or for targeting mesenchymalized carcinoma cells via direct or immune-mediated killing.